These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 12052918

  • 1. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.
    Steinman L, Martin R, Bernard C, Conlon P, Oksenberg JR.
    Annu Rev Neurosci; 2002; 25():491-505. PubMed ID: 12052918
    [Abstract] [Full Text] [Related]

  • 2. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS.
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract] [Full Text] [Related]

  • 3. New concepts in the immunopathogenesis of multiple sclerosis.
    Hemmer B, Archelos JJ, Hartung HP.
    Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559
    [No Abstract] [Full Text] [Related]

  • 4. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.
    Steinman L.
    Cell; 1996 May 03; 85(3):299-302. PubMed ID: 8616884
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Experimental autoimmune encephalomyelitis relapses are reduced in heterozygous golli MBP knockout mice.
    Voskuhl RR, Pribyl TM, Kampf K, Handley V, Liu HB, Feng J, Campagnoni CW, Soldan SS, Messing A, Campagnoni AT.
    J Neuroimmunol; 2003 Jun 03; 139(1-2):44-50. PubMed ID: 12799019
    [Abstract] [Full Text] [Related]

  • 7. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
    Taoufik E, Tseveleki V, Euagelidou M, Emmanouil M, Voulgari-Kokota A, Haralambous S, Probert L.
    Neurodegener Dis; 2008 Jun 03; 5(1):32-7. PubMed ID: 18075273
    [Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD, Nave KA.
    Annu Rev Neurosci; 2008 Jun 03; 31():247-69. PubMed ID: 18558855
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN, Snyder DS.
    CRC Crit Rev Clin Neurobiol; 1984 Jun 03; 1(1):45-82. PubMed ID: 6400508
    [Abstract] [Full Text] [Related]

  • 11. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ, Agrawal HC.
    Prog Clin Biol Res; 1984 Jun 03; 146():199-206. PubMed ID: 6201891
    [No Abstract] [Full Text] [Related]

  • 12. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG, Moscarello MA.
    J Neurosci Res; 2005 May 01; 80(3):301-8. PubMed ID: 15704220
    [Abstract] [Full Text] [Related]

  • 13. Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
    Sheremata W, Cosgrove JB, Robb P.
    Trans Am Neurol Assoc; 1973 May 01; 98():306-9. PubMed ID: 4784962
    [No Abstract] [Full Text] [Related]

  • 14. Human immune studies in multiple sclerosis.
    Bar-Or A.
    Adv Neurol; 2006 May 01; 98():91-109. PubMed ID: 16400829
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The pathology of MS: new insights and potential clinical applications.
    Pittock SJ, Lucchinetti CF.
    Neurologist; 2007 Mar 01; 13(2):45-56. PubMed ID: 17351524
    [Abstract] [Full Text] [Related]

  • 17. Animal models for multiple sclerosis.
    Owens T.
    Adv Neurol; 2006 Mar 01; 98():77-89. PubMed ID: 16400828
    [No Abstract] [Full Text] [Related]

  • 18. Is there a rationale for therapeutic immunoadsorption in multiple sclerosis?
    Berger T.
    Eur J Clin Invest; 2005 Aug 01; 35(8):467-8. PubMed ID: 16101665
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S.
    Neurology; 2007 May 29; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.